Quarterly report pursuant to Section 13 or 15(d)

Fair Value Measurements (Details Narrative)

v3.21.2
Fair Value Measurements (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2020
Fair Value Measurement Inputs and Valuation Techniques [Line Items]          
Fair value of derivative liabilities $ 8,955,336   $ 8,955,336   $ 455,336
Derivative liabilities 455,336   $ 455,336   455,336
Percentage of market price     85.00%    
Fair Value Conversion Option 0 $ 0 $ 0 $ 0  
Deemed dividends $ 99,300,000 $ 3,200,000 $ 149,600,000 $ 3,200,000  
Derivative [Member] | Minimum [Member]          
Fair Value Measurement Inputs and Valuation Techniques [Line Items]          
Fair value assumptions, measurement input, percentage 0.06%   0.06%    
Fair value assumptions, measurement input, percentage 216.72%   213.25%    
Derivative [Member] | Minimum [Member] | Measurement Input, Expected Term [Member]          
Fair Value Measurement Inputs and Valuation Techniques [Line Items]          
Fair value assumptions, measurement input, weighted average remaining term 7 months 28 days   7 months 28 days    
Derivative [Member] | Maximum [Member]          
Fair Value Measurement Inputs and Valuation Techniques [Line Items]          
Fair value assumptions, measurement input, percentage 0.07%   0.10%    
Fair value assumptions, measurement input, percentage 253.20%   253.20%    
Derivative [Member] | Maximum [Member] | Measurement Input, Expected Term [Member]          
Fair Value Measurement Inputs and Valuation Techniques [Line Items]          
Fair value assumptions, measurement input, weighted average remaining term 1 year   1 year 2 months 15 days    
VisualMED Series B Preferred Stock [Member]          
Fair Value Measurement Inputs and Valuation Techniques [Line Items]          
Fair value of derivative liabilities $ 8,500,000   $ 8,500,000